TransMedics is a U.S.-based company founded in 1998 to address the growing need for more viable organs for transplantation. Its mission is to advance standards of care in transplant medicine by increasing the utilization of available organs, improving patient outcomes, and enhancing the overall sustainability of transplant processes.
The company operates globally and is also present in Italy with its own local office.
The company has developed and commercializes the Organ Care System (OCS™), an innovative platform for the preservation and transportation of hearts, lungs, and livers intended for transplantation.
OCS is the first multi-organ platform built on shared proprietary technologies, designed to maintain organs in controlled physiological conditions and overcome the limitations of traditional preservation techniques.
